| |
|
ABSTRACT |
SLIDES |
|
| 08.15 |
Registration – Tea & Coffee |
|
|
|
| 08.45 |
Welcome & Agenda |
|
|
R Laing; S Langley (UK) |
| |
Session 1
Best Treatment/Practice for Localised High Risk Prostate Cancer: Oncological and Functional Outcomes
(PSA+20, Gleason 8-10, T2c+) |
|
|
Chair: J Money-Kyrle (UK) |
| 09.00 |
HDR Brachytherapy |
|
 |
Nikos Tselis |
| 09.15 |
LDR Brachytherapy |
|
|
B Moran (USA) |
| 09.30 |
Radical Surgery |
|
|
S Machtens (Germany) |
| 09.45 |
EBRT and Role of Hormones |
|
|
M Zelefsky (USA) |
| 10.00 |
Discussion |
|
|
|
| 10.30 |
Tea & Coffee |
|
|
|
| |
Session 2
Focal Therapy |
|
|
Chair: S Machtens (Germany) |
| 11.00 |
The Role of mpMRI in Prostate Cancer Detection/Focal Therapy |
|
|
A Kirkham (UK) |
| 11.20 |
Focal Brachytherapy: UK experience |
|
|
S Langley (UK) |
| 11.40 |
Focal Brachytherapy: USA experience |
|
|
M Zelefsky (USA) |
| 12.00 |
Panel Discussion and Q&A |
|
|
|
| 12.15 |
Abstract Presentations |
|
|
|
| |
Oral and Poster |
|
|
|
| |
MRI – Ultrasound Fusion Targeted Biopsies (M-U FTB) using Varian Brachytherapy Software |
 |
|
Rick Popert |
| |
Comparison of Day-0 Ultrasound Real-time Dosimetry with Day 0 and Day 30 CT-based Dosimetry for Permanent Prostate Implants using 125I Single Seeds-Initial Study |
|
|
Louise Fahy |
| |
Outcome of Patients Treated with Salvage Brachytherapy for Local Failure after Initial External Beam Radiotherapy for Prostate Cancer: Galway Experience |
|
|
Jamsari Khalid |
| |
Dosimetry Modeling for Focal LDR Prostate Brachytherapy |
|
|
Bashar Al-Qaisieh |
| |
Poster |
|
|
|
| |
The Use of Failure Mode Effect Analysis to Enhance Quality in Prostate Seed Brachytherapy |
|
|
Colin Kelly |
| |
Simple Positional Optimisation Allows Optimal Treatment Delivery to Larger Prostate Glands |
|
|
David Wood |
| |
Lean Principles in HDR Prostate Brachytherapy Significantly Reduces Procedure Time |
|
|
Michelle Boyle |
| |
Cone Beam vs. Conventional CT in I125 Prostate Brachytherapy |
|
|
Patrick Leydon |
| |
Can a Mentored Training Program Help Overcome the Learning Curve for Prostate Seed Brachytherapy? Initial Experience at a Single Irish Centre |
|
|
Paul J Kelly |
| |
An Update on Urinary Engrailed-2 (EN2), a Novel Biomarker for Detection of Prostate Cancer and its Correlation with Tumour Volume and Pathological Stage |
|
|
Saqib Javed |
| |
Prostate Brachytherapy – Equal Access for All? |
|
|
Caroline Manetta |
| |
A Report on the Initial Experience of the BARD ‘Prolink Brachytherapy System’ in the Treatment of early stage Prostate Cancer |
|
|
Stephen Thompson |
| |
Median Lobe Resection followed by Delayed Permanent Seed Prostate Brachytherapy: A Retrospective Analysis of Urinary Toxicity |
|
|
Kasia Owczarczyk |
| 13.00 |
Lunch |
|
|
|
|
|
Session 3 |
|
|
Chair: R Laing (UK) |
| 14.00 |
Challenging Cases (submitted by panel and audience)
Audience Questions and Discussion |
|
|
Panel: B Moran (USA);
M Zelefsky (USA);
S Machtens (Germany);
P Hoskin (UK);
S Khaksar (UK) |
| 14.45 |
LDR Brachytherapy or EBRT in Early Disease |
|
|
M Zelefsky (USA) |
| 15.00 |
Brachytherapy in Modern US Healthcare
|
|
|
B Moran (USA) |
| 15.20 |
HDR – Results and Future Studies in Monotherapy |
|
|
P Hoskin (UK);
Nikos Tselis |
| 15.55 |
Prize for Best Abstract & Closing Remarks |
|
|
R Laing;
S Langley (UK) |
| 16.00 |
Meeting Close |
|
|
|
